Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
07/2005
07/14/2005WO2005063010A1 A novel use of neuroactive compounds
07/14/2005WO2005063009A1 A procedure for screening of neuroactive substance and the associated neural plasticity
07/14/2005WO2005063008A2 System for breeding insects
07/14/2005WO2005063007A1 Non-human mammal comprising a modified serca2 gene and methods, cells, genes, and vectors thereof
07/14/2005WO2005062780A2 In vivo odorant receptor systems and their uses
07/14/2005WO2005033274A3 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
07/14/2005WO2004078939A3 REGULATION OF Mdm2 FUNCTION
07/14/2005US20050155098 Expression vector comprising reporter gene for as tool to establish stable supply of fluorescent fish with desired transgenes; bioreactor for heterologous gene expression
07/14/2005US20050155097 Recombinant rodents comprising expression vector coding a toxin and somatotropin for use as tools in the study of pathologies and treatments relating to tissues and organ systems that typically contain eosinophils
07/14/2005US20050155096 Expression vector comprising nucleotide sequences granulocyte colony stimulating factor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders
07/14/2005US20050155095 Porcine Isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region
07/14/2005US20050155094 Expression vector comprising nucleotide sequences coding human recombination activating protein (RAG-1) gene for use as tool in generating immunodeficient pigs; animal models and immunotherapy
07/14/2005US20050155093 Using embryo transfer to generate modified animal model; tissue engineering; bioreactor for heterologous protein expression
07/14/2005US20050155092 Mutant muscle protein nucleotide sequences for use in generating animal models for diagnosis and treatment of cardiovascular disorders
07/14/2005US20050155091 Protein kinase gamma (Prkag3 ) regulator sequences for use as tool in directing heterologous gene expression and proteins for treatment of diabetes, obesity, insulin resistance and dyslipidemia
07/14/2005US20050155087 Method of screening compounds
07/14/2005US20050154592 Vocal connection system between humans and animals
07/14/2005US20050153922 MutS homolog 5 (MSH5); gene expression inhibition; for modulation of fertility
07/14/2005US20050153909 Producing a cell that contains heterologous nucleic acid byintroducing a satellite artificial chromosome (SATAC) into the cell
07/14/2005US20050153440 Using embryonic germ cell as model for monittoring and evaluating genomic imprinting; tissue engineering; tissue targeted therapy; regenerative medicine; gene silencing
07/14/2005US20050153407 Chemoenzymatic methods for the synthesis of statins and stain intermediates
07/14/2005US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders
07/14/2005US20050153287 Nr3b nmda receptor subunit compositions and related methods
07/14/2005CA2552150A1 Means for stimulation and activation of hair growth by il-15
07/14/2005CA2551696A1 Immunopotentiator and method of enhancing immunoactivity using the same
07/14/2005CA2550356A1 Heh4 molecules and uses thereof
07/14/2005CA2455741A1 Bee nest surround
07/13/2005EP1553190A2 Mutations in and genomic structure of HERG - a long QT syndrome gene
07/13/2005EP1553180A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide
07/13/2005EP1552741A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds
07/13/2005EP1552740A1 Chimeric murine model comprising human hepatocytes - use for screening compounds
07/13/2005EP1552739A1 Hepatic cirrhosis model animal and method of constructing the same
07/13/2005EP1552310A2 Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
07/13/2005EP1551973A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
07/13/2005EP1551971A2 Sirna mediated gene silencing in transgenic animals
07/13/2005EP1551872A2 G-protein coupled receptors
07/13/2005EP1551857A2 A robust, inducible cardiac preferred expression system for transgenesis
07/13/2005EP1551443A2 Proteins involved in the regulation of energy homeostasis
07/13/2005EP1551222A2 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny
07/13/2005EP0681431B1 Production of human recombinant collagen in the milk of transgenic animals
07/13/2005CN1639333A Process for producing physiologically active protein using genetically modified silkworm
07/13/2005CN1638800A Human monoclonal antibodies against CD30
07/13/2005CN1638799A Human mast cell-expressed membrane proteins
07/13/2005CN1636597A Compounds for the treatment of female sexual dysfunction
07/13/2005CN1636448A Ecological no-hibernation snake cultivating method
07/13/2005CN1636447A Ecological combined smoke cultivating cage and its making process
07/13/2005CN1210066C Cloning pigs using donor nuclei from differentiated cells
07/12/2005US6916654 Universal donor cells
07/12/2005US6916632 Generation of preferential configured nucleotide sequences; obtain nucleotide sequences, incubate with topoisomerase, link sequences and recover products
07/12/2005US6916631 Comprises monoclonal antibody for diagnosis and treatment of skin disorders
07/12/2005US6916625 Artery- and vein-specific proteins and uses therefor
07/12/2005US6916603 Administering a test agent; monitoring expression of Delta FosB to determine whether the agent modulates bone formation
07/07/2005WO2005061736A2 Sleep genes in drosophila and their use for the screening, diagnosis and therapy of sleep disorders
07/07/2005WO2005060997A2 Medicament comprising inhibitors of long pentraxin ptx3
07/07/2005WO2005060739A1 Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar
07/07/2005WO2005042693A3 Hla-e chimeric molecule
07/07/2005WO2005035729A3 A genetic screen in drosophila for metastatic behavior
07/07/2005WO2005030269A8 Endotoxin-nonresponsive model animal
07/07/2005WO2004050007A3 Mammalian bt-42 proteins involved in the regulation of energy homeostasis
07/07/2005WO2003089583A3 Tissue specific genes and gene clusters
07/07/2005US20050149999 Methods for cloning mammals using remodeling factors
07/07/2005US20050149997 Sterilization of marine organisms by manipulation of DNA content
07/07/2005US20050149995 Using transgenic animal cells as bioreactor for propagation of connective tissue protein for use in treatment of collagen diseases
07/07/2005US20050149994 Rapidly maturing fluorescent proteins and methods for using the same
07/07/2005US20050149993 Transgenic mouse for use as model in identifying modulators for prevention and treatment of circadian rythm disorders
07/07/2005US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders
07/07/2005US20050148013 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
07/07/2005US20050147969 Genes associated with mast cell activation
07/07/2005US20050147650 Feed for silkworm, silk produced from silkworms that feed on the feed for silkworm, and silk products made from the silk
07/07/2005CA2548452A1 Medicament comprising inhibitors of long pentraxin ptx3
07/06/2005EP1549940A2 Transgenic animal model for spliceosome-mediated rna trans-splicing
07/06/2005EP1549664A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
07/06/2005EP1549353A2 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
07/06/2005EP1230375B1 Inhibiting gene expression with dsrna
07/06/2005CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
07/06/2005CN1633846A Method for promoting wood frog survival rate through reproductive dormancy and spring dormancy
07/06/2005CN1633845A Siberian frog gastroenteritis, skin rot prevention and curing method
07/06/2005CN1209457C Preparation and selection of donor cells for nuclear transplantation
07/06/2005CN1209011C Method for ecotypic breeding frog
07/05/2005US6914124 Tetracycline-regulated transcriptional activator fusion proteins
07/05/2005US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
07/05/2005US6913892 Method of obtaining compositions comprising Y4 specific compounds
07/05/2005CA2215793C Use of neuronal apoptosis inhibitor protein (naip)
06/2005
06/30/2005WO2005059562A2 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases
06/30/2005WO2005058028A2 Novel gene disruptions, compositions and methods relating thereto
06/30/2005WO2005058025A2 Renewably buoyant, self-protective floating habitat
06/30/2005WO2004093788A3 Desmoglein 4 is a novel gene involved in hair growth
06/30/2005WO2004042062A9 Porcine uroplakin ii promoter and the production method of useful proteins using said promoter
06/30/2005US20050144663 Producing transgenic animals for obtaining useful proteins; combining genome from activated donor cell with activated, enucleated oocyte to form nuclear transfer embryo for impregnation
06/30/2005US20050144662 Knockout mouse
06/30/2005US20050144661 Robust, broadly applicable bioluminescence signal; demonstrates modification independent and phosphorylation dependent protein interactions; diagnostic and testing tool; transgenic animal models
06/30/2005US20050144660 Mouse models for studying and treating hepatocellular and gastrointestinal tumors
06/30/2005US20050144659 Animals and cells containing a mutated alpha2delta gene
06/30/2005US20050144657 Transfecting rhesus papillomavirus (RhPV) genome into raft culture of rhesus cervical cells or foreskin keratinocytes with DNA molecule; inducing heat shock protein 40 and 70 expression enhancing viron growth
06/30/2005US20050144656 treating fruitflies (Drosophila melanogaster) with medium containing strychnine, pentylenetetrazol, tetraethylammonium chloride, lithium carbonate and nicotine, then crossing to produce inheritable changes in locomotor behavior
06/30/2005US20050144655 Methods of modifying eukaryotic cells
06/30/2005US20050144654 treating fruitfly Drosophila melanogaster adult males with fly medium containing either of neuroactive compounds strychnine, pentylenetetrazol, pilocarpine hydrochloride, tetraethylammonium chloride, lithium carbonate and ethosuximide, subjecting flies to negative geotaxis and horizontal locomotor assays
06/30/2005US20050142634 Novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof
06/30/2005US20050142568 Kit for screening for an apoptosis modulator; an isolated cell death-related nuclease (CRN)polypeptide or fragment, polynucleotide encoding fragment, and/or orthologs; medical diagnosis; genetic engineering and expression; hybridization
06/30/2005US20050142566 Sperm-specific cation channel, catSper2, and uses therefor